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. Moreover, the physical changes typical for the tumor stroma, such as increased collagen density and matrix stiffness, can promote tumorigenesis and invasion (7) . Elucidating the effects of the physical microenvironment on the soluble proteins in the tumor IF can provide important design parameters for therapeutic agents (32) .
How the steric and electrostatic exclusion by ECM elements affect the distribution of proteins have been studied in vitro and in vivo in animal tumor models (21) (for review see Ref. 51) . Despite the potential clinical importance, data on available and thus excluded volumes in human tumor tissue have to our knowledge not been presented earlier. This may in part be due to the inaccessibility of native IF from human tissue, an issue that can be resolved by using centrifugation for isolation of human tumor interstitial fluid (TIF) (16, 51) . Furthermore, high-resolution mass spectrometry (MS) enables quantification of the endogenous abundant plasma proteins present in IF and in tissue eluate by spectral counting (32) that can be used as probes for quantification of the exclusion effect of both normal and malignant human tissues.
We asked whether ECM structural changes observed in experimental animals were reflected in malignant human ovarian tissue. Using plasma proteins as probes we moreover asked whether the tumor ECM excludes macromolecules from a substantial part of the TIF in vivo. We hypothesized that steric exclusion as well as fixed negative charges in the ECM influences the distribution volume of macromolecules, implicating reduced accessibility for macromolecular therapeutic agents. Upon analysis of TIF we found that unfractionated fluid has high concentrations of earlier suggested biomarkers for ovarian and endometrial carcinoma, and may be a valuable substrate for identification of tumor-specific proteins. Surprisingly, we found that the distribution volume of albumin was actually increased in malignant ovarian tissue, most likely due to a reduced amount of collagen and increased hydration compared with that of healthy ovarian tissue. The high tumor tissue hydration was also the likely reason for the modest charge effect on macromolecular distribution volumes. Abundant plasma proteins in unfractionated TIF can accordingly be used to model drug uptake as a function of ECM structure in the tissue.
MATERIAL AND METHODS

Collection of Tissue and Blood Samples from Patients
The research protocol has been approved by the Norwegian Data Inspectorate (Protocol No. 961478-2), Norwegian Social Sciences Data Services (Protocol No. 15501), and the local ethical committee (Protocol ID REKIII nr. 052.01). All samples were collected after obtaining the patients= written informed consent. The work conformed to the standards set by the latest revision of the Declaration of Helsinki.
Tissue samples of ovarian carcinomas (OC) and endometrial carcinomas (EC) were collected from the Department of Obstetrics and Gynecology at Haukeland University Hospital during surgery. The samples were taken from the tumor surface in an area without any apparent necrosis or inflammation. Tissue from healthy ovaries obtained during surgery of cervical and endometrial cancer without affected ovaries served as healthy ovarian control tissue (OH). Blood samples were collected from the patients 1 to 2 days before surgery, and EDTA was added as the anticoagulation agent before isolation of plasma by centrifugation. The tissue samples were cut in two, and TIF was isolated from one part of the fresh tissue ϳ60 min after extirpation by centrifugation through a mesh-filter at 106 g for 10 min as described earlier (16, 48) . The centrifuged tissue was dried at 60°C for 48 h to determine its water content. TIF was pipetted off avoiding erythrocytes and stored at Ϫ80°C until further processing. The second half of tissue was minced into 1-3 mm 3 pieces and incubated with gentle rotation for 48 h at 4°C in a potassium buffer of 0.137 M KCl, 0.05 M H2KPO4, and 0.02% potassium azide (pH 7.4) with aprotinin (0.128 TIU/ml) as an antiproteolytic agent. The sample was then centrifuged at 3,220 g for 20 min at 4°C, and the supernatant was pipetted off. The tissue samples and eluate were frozen at Ϫ80°C until further analysis.
Albumin Concentration Measured by HPLC
Particles from eluate were removed by filtering samples through 0.22 m syringe filters. Fifty microliters of filtered eluate was diluted 1:2 in phosphate buffer containing (in M) 0.1 Na 2SO4, 0.05 HNa2PO4, and 0.05 H2NaPO4 (pH 6.8), whereas plasma and TIF were diluted 1:336 in phosphate buffer. All samples were analyzed by HPLC using a size-exclusion column (Super SW2000, 4.6 ϫ 300 mm, 18674; Tosoh Bioscience, Tokyo, Japan) and reversed phase column (Proswift Rp4H 1 ϫ 50 mm; Dionex, Sunnyvale, CA) coupled in series. Albumin was separated from IgG and other larger plasma proteins in the first dimension. Subsequently, the sample that eluted in the retention time of albumin was loaded onto the second column by an inline switch at a flow rate of 0.35 ml/min and with an 8-min acetonitrile gradient (5-60%) for separation from proteins with similar molecular weight and quantification of the albumin peak. The albumin concentration was determined based on the area under the curve for standards and samples (16, 48) .
Measurement of Na ϩ
Eluate samples (500 l) were concentrated using Amicon Ultra-4 Centrifugal Filter Units with 3 kDa cutoff (Millipore, Milford, MA). Na ϩ concentration in filtrate and TIF was determined as described previously (16, 48) .
Disintegration of Tissue
The tissue from elution was freeze-dried and incubated in digestion buffer (10 mg dried tissue/ml buffer) for 18 h at 65°C. The digestion buffer consisted of 0.150 mg/ml papain (Sigma, St. Louis, MO) in 0.2 M phosphate buffer containing 0.1 M HNa 2PO4 and 0.1 M H2NaPO4 (pH 6.4) with 0.1 M sodium acetate, 0.01 M Na2EDTA, and 0.005 M cysteine HCl. The samples were centrifuged at 20,000 g for 20 min, and the supernatant was pipetted off and stored at Ϫ20°C for further analysis. Ovarian cancer  1  Mucinous borderline tumor  IA  NA  82  2  Papillary serous adenocarcinoma  IIIC  3  69  3  Papillary serous adenocarcinoma  IIIC  3  70  4  Serous adenocarcinoma with low differentiation  IIIC  3  54  5  Clear celled adenocarcinoma  IV  NA  48  6  Papillary serous adenocarcinoma  IV  NA  42  7  Papillary serous adenocarcinoma  IIIC  3  54  8  Serous adenocarcinoma  IIIC  3  66  9  Mucinous borderline tumor  IC  NA  80  10  Papillary serous adenocarcinoma  IIB  3  64  11  Serous adenocarcinoma  IIIC  3  68  12  Papillary serous adenocarcinoma  IIIC  3  85  Endometrial cancer  13  Undifferentiated carcinoma  IIIC  3  65  14  Adenocarcinoma, endometrioid type, low differentitation  IIIC1  2  67  15 Adenocarcinoma 
Estimation of Components of the Extracellular Matrix
Collagen content was determined by measuring hydroxyproline according to Woessner (52) as described in a previous publication (48) .
Sulfated GAG (sGAG) concentration was measured using the Blyscan sulfated Glycosaminoglycan Assay (BC-B1000; Biocolor, Carrickfergus, U.K.) and hyaluronan (HA) with a hyaluronic acid test kit (Catalog number 029-001; Corgenix, Broomsfield, CO) following instructions provided by manufacturers.
Protein Identification by Mass Spectrometry
The protein concentration in TIF, plasma, and Amicon-filtered eluate was determined by Qubit Quant-IT Protein Assay Kit (Invitrogen, Carlsbad, CA), and ϳ30 g of protein from plasma, TIF, and eluate samples were diluted to 30 l with 100 mM ammonium bicarbonate, digested by trypsin and desalted as described earlier (16, 48) .
Iontrap. TIF and eluate samples were analyzed twice in triplicate by liquid chromatography (LC) coupled to tandem mass spectrometry (MS/MS) on an Agilent 1100 LC/MSD Trap XCT Plus system with a HPLC-Chip/MS interface. The HPLC-Chip contained a 0.075 ϫ 43 mm ZORBAX 300SB C18 5-m column and an integrated 9 mm 160 nl enrichment column packed with the same material (part no. G4240-63001 SPQ110; Agilent Technologies).
Label-free analysis of individual samples with LTQ orbitrap velos pro. Digested TIF samples were analyzed using an LTQ Orbitrap Velos Pro mass spectrometer (Thermo Scientific, Waltham, MA) as described earlier (17) .
The software Progenesis LC-MS (Nonlinear Dynamics, Newcastle, UK) was used for label-free quantification and comparison of LC-MS Orbitrap data as previously detailed (17) .
Calculation of Protein Distribution Volumes
To assess the distribution volumes of a larger number of proteins with a span of molecular size and charge, we used the spectral data from the most abundant plasma proteins detected in native IF after MS-analysis. The extracellular distribution volume V A for protein x, VAx, was calculated as VAx ϭ [(EX/SX) Ϭ (EAlb/SAlb)]·VAlb, where S is the number of spectra detected in IF, E is the number of spectra detected in eluate, and V Alb is the distribution volume for albumin.
Statistical Analysis
SPSS (IBM SPSS Statistics, version 19.0.0.2; IBM, Armonk, NY) and Graphpad Prism (Software version 5.0; Graphpad Software, La Jolla, CA) were used for statistical analysis, and data were compared using nonparametric Mann-Whitney tests unless otherwise specified. A P value of Ͻ0.05 was considered statistically significant. All values are presented as means Ϯ SE.
RESULTS
The mean age of all patients included in this study was 67.1 Ϯ 11.4 years, and there was no statistical difference between the ages of the patients at surgery in different groups. An overview of the samples used with age, diagnosis, and histological subtype is given in Table 1 .
Fluid Volumes
Hydration. We first measured water content since this parameter is an important determinant of the space accessible to proteins (51) . Median water content was slightly elevated in OC (P ϭ 0.011) and EC (P ϭ 0.016) compared with OH (Fig.  1A and Table 2 ), whereas the water content in EC and OC did not differ significantly. Three samples in OC had a marked higher hydration than the other samples in the OC group, the two mucinous carcinomas (samples 1 and 9), and a serous ovarian carcinoma (sample 7).
Total extracellular volume. Because Na ϩ is found predominantly in the extracellular fluid, we can calculate the total extracellular volume (ECV) in the tissue samples by using the concentration of Na ϩ in eluate, yielding total mass of Na ϩ , and in IF, yielding the extracellular concentration. A requirement is that the isolated sample is of extracellular origin, as can be assessed by the -ratios for OC and OH were both 0.8 Ϯ 0.3, not significantly different from 1.0, whereas the ratio for EC, 0.5 Ϯ 0.2, was significantly lower than 1.0 (P Ͻ 0.05, Wilcoxon signed rank test), indicating admixture of intracellular fluid and possibly also a higher cellularity in EC. Such admixture precluded the use of Na ϩ concentration to calculate ECV in EC, and therefore ECV was calculated in OC and OH only. The Na ϩ -space, and thus extracellular volume of OC and OH, was 0.49 Ϯ 0.05 and 0.53 Ϯ 0.05 ml/g wet weight (ww), concurrent with earlier determinations of ECV in experimental animal tumors (27, 51) .
Distribution volume of albumin. The matrix elements of the interstitium will limit the space available for macromolecules from a fraction of the interstitial fluid. In analogy with the estimation of total ECV using Na ϩ above, we calculated the available volume for albumin using the albumin concentrations in IF and the corresponding mass calculated from eluate concentration. Thus the albumin distribution volume was 0.33 Ϯ 0.04 and 0.26 Ϯ 0.02 ml/g ww for OC and OH, respectively, or 67% and 49% of the extracellular volume. Although the absolute distribution volumes for albumin were not different between OC and OH, the fractional available volume was significantly higher in OC compared with OH (P ϭ 0.04).
Distribution volume of abundant plasma proteins assessed by MS. We then asked whether the distribution volume, V A , was dependent on molecular weight or charge in healthy or malignant gynecologic tissue. To this end we determined V A for 15 known abundant plasma proteins that were detected by more than three spectra in both IF and eluate in all patients (Table 3) , and included proteins with molecular weights ranging from 40 to 190 kDa, and pI from 1.8 to 8.6. The concentration of soluble proteins in isolated IF was not significantly different for OC, EC, and OH (Table 2) , averaging 45.1 Ϯ 12.2 mg/ml across all samples.
To determine whether V A is dependent on molecular size, we expressed V A as a function of molecular weight for all 15 plasma proteins used as probes (Fig. 1B) . The distribution volumes in EC and OH were decreasing with increased molecular weight (linear regression, P ϭ 0.033 and P ϭ 0.003, respectively), whereas this relationship was not significant in OC (P ϭ 0.16). Of note, IgG (146 kDa), previously used as probe in rat tumors (49) , had V A of 0.34 Ϯ 0.02 ml/g in OC and 0.32 Ϯ 0.02 ml/g in OH, not different from that of albumin (P ϭ 0.23 and P ϭ 0.12 for OC and OH, respectively). Furthermore, the dependence of V A as a function of pI, and thereby of protein charge, was regarded using all proteins, as well as by grouping the proteins according to molecular weight. The distribution volume did not show correlation with pI when considering the entire molecular weight range, nor in the low molecular weight area (57-77 kDa, results not shown). In the high molecular weight range (137-180 kDa) the distribution volume in OH increased for proteins with increasing pI (Fig. 1C) ; thus proteins with a more positive charge at physiologic pH had an increased distribution volume compared with negatively charged proteins of similar size in OH.
ECM Components
Tumor tissue can have a heterogeneous ECM composition that may affect macromolecular distribution volume (25) . We therefore estimated the concentrations of the extracellular components collagen, HA, and sGAGs in all excised tissue samples used for determination of V A (Table 2) .
Collagen. The collagen contents of both ovarian (P ϭ 0.0087) and endometrial (P ϭ 0.00053) carcinomas were significantly lower than that in the healthy ovarian tissue (Table 2 and Fig. 2A ). Negligible amounts of collagen were detected in eluates.
sGAGs. The concentrations of sGAGs in the tissue were not significantly different in OC, EC, and OH (Fig. 2B and Table  2) , with eluates containing negligible amounts of sGAGs.
The IF samples were also analyzed by MS, and 10 proteoglycan proteins were detected in the material: Versican core protein (P13611); Aggrecan core protein (P16112); Lumican (P51884); Fibromodulin (Q06828); Dystroglycan (Q14118); Basement membrane-specific heparan sulfate proteoglycan core protein (P98160); Hyaluronan and proteoglycan link protein 2 (Q9GZV7); Proteoglycan 4 (Q92954); Agrin (O00468) and Decorin (P07585), of which four were significantly upregulated in OC compared with OH (Versican core protein, Lumican, Aggrecan core protein and Fibromodulin, P Ͻ 0.05, Kolmogorov-Smirnov test). Summarizing the normalized abundance for all 10 proteins, the difference between OC and OH remained significant (P ϭ 0.003).
Hyaluronan. Because repeated elution and subsequent centrifugation can release up to 40% of the tissue HA in solution (1), we analyzed the eluate for HA. We found that ϳ20% of the HA originating from the tissue could be found in the tissue eluate of OC and OH, whereas significantly more HA in EC tissue was released during elution (60%) compared with both OH and OC. Analysis of HA in tissue and eluate ( Fig. 2C and Table 2) showed that the HA concentration of OC (P ϭ 0.0049) and EC (P ϭ 0.0055) was significantly higher than for OH.
MS analysis showed that CD44 antigen (P16070) was upregulated in EC compared with OH (Kolmogorov-Smirnov test, P ϭ 0.02), and Inter-␣-trypsin inhibitor heavy chain H3 (Q06033), which can act as a binding protein for HA and other matrix proteins in tissue, was upregulated in both EC (P ϭ 0.02) and OC (P ϭ 0.05) compared with OH.
IF Proteome
We used a MS-based strategy to quantify multiple abundant plasma proteins with different size and charge as probes to address the question of how these factors affect their distribution volume in the tissue microenvironment. A positive side effect of this approach was the quantification of other proteins that may give functional information about the biological processes in the tissue. The medium-to-high abundance proteomes of IF, eluate, and plasma yielded 1,590, 1,864, and 381 proteins that were identified in one or more of the IF, eluate, and plasma samples, respectively (Fig. 3) . Of all the proteins detected in one or more of the proteomes, 45%, 48%, and 70% were found in all three groups for IF, eluate, and plasma, respectively. EC had the most proteins only detected in one proteome in IF and eluate (22% and 16%), probably reflecting the increased cell lysis indicated by the low Na ϩ -ratio, whereas OC had the largest number of unique proteins in plasma (11%).
The much larger number of proteins in IF compared with plasma underlines the advantage of using IF over plasma as a starting point for biomarker discovery, and we assessed the potential of this approach for biomarker discovery by a brief analysis of a few proposed biomarker candidates.
Tumor-specific proteins. To assess the potential of the identified proteomes as a source for biomarker candidates, we selected the 587 proteins with a P value less than 0.05 when comparing EC with OH, OC with OH, or EC with OC, judged by the Kolmogorov-Smirnov test, and compared these proteins 
. Extracellular matrix components in OC, EC, and OH expressed as dry tissue weight (dw).
A: collagen content (nOC ϭ 12, nEC ϭ 9, nOH ϭ 8). **P Ͻ 0.01; ****P Ͻ 0.0001, Mann-Whitney test. B: sulphated glucosaminoglycans (sGAG; nOC ϭ 12, nEC ϭ 9, nOH ϭ 8). C: hyaluronan (HA; nOC ϭ 11, nEC ϭ 8, nOH ϭ 7). ***P Ͻ 0.001, Mann-Whitney test.
to the list of known biomarkers compiled by Polanski and Anderson (33) . From our data set, 81 proteins, or 14% (Table  4) , were corresponding to those reviewed by Polanski and Anderson (33) . Of these, we looked closer at three proteins. Stathmin (P16949) was upregulated in EC compared with OH ( Fig. 4A ; P ϭ 0.012), and the S100 calcium binding proteins A8 (P05109) and A9 (P06702) were found in significantly higher amounts in EC compared with both OH (P ϭ 0.012; Fig. 4B ) and OC (P ϭ 0.004; KS). Two related proteins, S100A4 and S100A13, were upregulated in OC compared with OH (data not shown).
In addition to the proteins that are common to the biomarker list compiled by Polanski and Anderson in 2007 (33), many proteins have been suggested as biomarkers since then, and we highlight four additional proteins that may be relevant for ovarian or endometrial cancer. Stress-induced phosphoprotein 1 (STIP1, P31948) was upregulated in both OC (P ϭ 0.028) and EC (P ϭ 0.012) compared with OH (Fig. 4C) . Histidinerich glycoprotein (HRG, P04196) was expressed in significantly higher amounts in OC compared with EC (P ϭ 0.01), with the same tendency between OC and OH, with borderline significance (P ϭ 0.07; Fig. 4D ). Spindlin-1 (Q9Y657), also called ovarian cancer-related protein, was significantly increased in OC compared with OH ( Fig. 4E ; P ϭ 0.009). Programmed cell death 6-interacting protein (PCD6I, Q8WUM4; Fig. 4F ) was identified with low expression in OH, whereas the expression in both EC (P ϭ 0.002) and OC (P ϭ 0.003) were significantly upregulated. By analyzing native samples of TIF from individual patients, we are able to detect several proteins that have earlier been suggested as biomarkers, and show that the abundance of tumor-specific proteins are sufficient for detection by a highresolution mass spectrometer such as the Orbitrap.
DISCUSSION
To our knowledge, data on directly measured extracellular and protein available volume have never been reported in human tumors. Here we determined the extracellular volume using Na ϩ as an internal tracer and label-free quantitative proteomics to identify and quantify abundant plasma proteins applied as endogenous probes. We could thereby assess protein available and excluded volume as a function of size and charge, and demonstrated a size-dependent exclusion of abundant plasma proteins between 40 and 190 kDa, as well as charge-dependent exclusion of high molecular weight proteins, in healthy ovarian tissue, but not in ovarian carcinoma. Serum albumin distributed in 67% of the extracellular space in OC, exceeding that of normal ovarium. These data are important when considering the concentrations of macromolecular therapeutic agents in the tumor microenvironment, as well as in designing novel treatments for ovarian and endometrial cancer.
Methodological considerations-limitations of the study. To measure available volume in the interstitium we need to estimate interstitial mass of the respective protein and its concentration in the interstitial fluid. Although we have evaluated the TIF isolation method thoroughly in an animal tumor model (48) and in human ovarian cancers (16) , and shown that the elution method gives complete protein recovery from skin (37) , the fact that we studied human tumors results in additional questions and poses limitations. One such question is the ϳ60-min period needed from tissue extirpation until TIF harvesting. During this period metabolic processes may result in tissue degradation and cell lysis and thereby contamination of TIF with intracellular proteins. Based on analyses of the mostly extracellular ion Na ϩ , there are no indications that cell lysis is a problem (16 quent fluid isolation would stop metabolism, but results in cell lysis and dilution of TIF (16) and is therefore not an alternative. Another challenge is that the tumor vascular structure is highly variable, contributing inter alia to a high interstitial fluid pressure (11) that may affect extracellular volume, hydration, and composition. We tried to minimize this effect by harvesting from the tumor surface in a standardized way from an area without any apparent necrosis or inflammation, but are aware that this may not be sufficient to completely compensate for this problem. Moreover, the intra-and extravascular protein composition may differ and result in a different concentration in native extravascular fluid and TIF, but such influence should be minimal due to a low extravascular volume fraction in tumors (48) . We used EC as an alternative tumor to OC to evaluate another tumor type and acknowledge that OH may not be a representative control for the former. Normal endometrium might have served as control for EC, but the endometrium in postmenopausal women is very thin and not suitable for TIF isolation by centrifugation. Moreover, if such tissue could be obtained it might not represent healthy tissue since patients treated for cancer in other sites in the gynecological tract (as ovarian cancer) are usually more advanced and often include growth into the uterus.
Because of a potential charge effect we decided to evaluate the tumor distribution volume of differentially charged probes. Because of limited sample volume we could not evaluate the pI of the applied probes as in a recent publication in rats (37) but had to use published values that may deviate from the actual ones. Most of the plasma proteins used as probes have a negative charge at normal pH and thus are less ionized in tumors because of the inherent lower pH in tumors (51) . Accordingly, the charge effect on distribution volume, shown to be substantial in skin in vitro (50) and in vivo (14) , may be underestimated by our present approach.
Relevance of data in relation to previous studies. We performed these experiments based on the hypothesis that ECM composition would affect macromolecular distribution and thereby tissue uptake, and further assessed the ECM composition in all three tissues to evaluate the contribution of ECM components to protein exclusion. As also demonstrated here, healthy ovarian tissue has a rather high concentration of collagen (34) , exceeding that in ovarian carcinoma. Interestingly, the concentration in human ovarian carcinomas is markedly higher than in ovarian tumor xenografts (8) as well as other animal tumor models (Table 3 in Ref. 51) . Thus, human tumor samples may have a substantially higher collagen content than tumors from animal models, underlining the importance of assessing ECM composition in clinical samples. For HA, however, the concentrations found in both EC and OC were comparable with that of ovarian tumor xenografts in mice (8) . These data were also consistent with earlier reports on an increase of HA in ovarian carcinomas relative to healthy ovarian tissue (18, 29) and endometrial carcinoma (29) . We had expected that the dense ECM in tumors (19, 25) and marked increase in negatively charged matrix components (43) would have resulted in a reduced distribution volume of the negatively charged albumin molecule, whereas the opposite was actually observed. Moreover, in contrast with findings in rat skin (49), we found that pI only affected V A in OH, the tissue with the lowest hydration, and only for proteins with molecular weight exceeding 138 kDa. Part of the explanation for the increased V A in OC can be a much lower absolute content of GAGs in ovarian tissue; another factor can be reduced ionization of acidic plasma proteins due to a lower pH in the tumor interstitium (51) as discussed above. However, the most important factor is likely the difference in hydration in the two tissues. Notably, the hydration measured in the human tissue is much higher than that observed in rat models (51) . By summarizing data from several studies we showed that there is a strong relationship between V A and hydration (51) . Such increased hydration will result in increased distances between both solid, neutral (notably collagen) and negatively charged tissue elements in the ECM and thus result in reduced exclusion due to steric as well as charge effects, explaining the observed lack of correlation between molecular weight and distribution volume. These assumptions are supported by mathematical modeling experiments (28) , and moreover by our finding of size and charge effects on distribution volume in the less hydrated OH. In line with this and with findings in rat tumors (49), we found similar V A for albumin and IgG in OC and OH. Whereas we have previously interpreted this observation to be a consequence of negative repulsive forces increasing the apparent size of albumin, it here appears to be resulting from lack of size sensitivity on V A in tissues with high hydration.
Others have studied the relationship between macromolecular size and distribution volume. Krol et al. (21) found that V A in tumor tissue decreased abruptly with probe sizes above 40 kDa, whereas the decrease in V A between 70 and 2,000 kDa was modest. The fact that all the plasma proteins used as probes here had molecular weights Ͼ40 kDa may explain the small reduction in V A with increasing molecular weight, concurrent with previous findings (21) .
EC had a higher V A than OH in the entire molecular weight range, but the reduction in V A at increasing molecular weight was similar to OH. Although the hydration of EC was somewhat higher than for OH, the size-dependent exclusion was evident for EC. However, the hydration of EC and OC was not significantly different, and the effect on V A can likely not be explained solely by hydration. Using a previous applied approach (49), we can estimate the exclusion effect for albumin caused by the individual ECM components and thereby interpret our data in the context of interstitial structure. We found an excluded volume of 33%, or 0.16 ml/g ww for OC and 51% or 0.27 ml/g ww for OH. Highly organized collagen will exclude albumin from 1.6 ml/g (4), whereas HA will contribute with 0.05 ml/mg (22) , and sGAGs with 0.044 ml/mg (49) . Using these numbers and our ECM structure data, we arrive at calculated theoretical albumin exclusion values of 0.24 and 0.33 ml/g ww for OC and OH, respectively, and thus a contribution of collagen, HA, and sGAGs of 20%, 2%, and 78% for OC, and 32%, 1%, and 67% for OH. The theoretical values are close to the measured, and the slight increase can be due to the differences in organization of the ECM components in vitro and in vivo. According to these estimates, the sGAGs are the major contributors to exclusion, whereas the difference in collagen content is the main cause for the discrepancy in albumin distribution volumes in OC and OH. Important to note, the large sGAGs will contribute substantial steric in addition to electrostatic exclusion. Taken together, such calculations give indications on which ECM component to be targeted to increase tissue uptake of macromolecular substances.
Relevance of data for biomarker studies. Although merely a distribution effect, the observed difference in available volume in healthy and cancer tissue might appear as a difference in protein expression. This should be borne in mind in biomarker discovery studies that use tissue samples, where proteins such as serum albumin, ceruloplasmin, and ␣-2-macroglobulin have been interpreted to be differentially expressed (46) . Such abundant plasma proteins are, however, mainly present in the tissue due to bulk flow and diffusion from blood, and the apparent difference in expression can be caused by variable ECM structure and protein distribution volume between patient groups. This is because a larger available volume will result in an increased total amount, but not in vivo concentration of a protein. Thus, when tissue samples are used for biomarker discovery, especially in the case of whole tissue, care should be taken to choose biomarker candidates that are likely locally produced.
Although our major aim was to use a proteomic approach to quantify several abundant macromolecular probes to be used, this approach also resulted in the identification of many proteins of interest in a biomarker context as might be expected using TIF as a substrate (12) . Several earlier reported biomarker candidates were here found to be increased in OC and EC compared with OH, such as stathmin (45) , several members of the S100 calcium binding protein group (9, 13, 38) , STIP1 (47), spindlin-1 (10), and PCD6I (30, 42) . Indeed, some were verified in clinical samples on protein level for the first time. Also, in contrast with earlier reports of reduced HRG in tumor tissue (35) , we actually found that HRG was higher in OC, which may be explained by the presence of HRG as a not actively regulated plasma protein that is affected by the sizedependent exclusion of OH and EC.
The proteins mentioned are only a few examples of possibly cancer-related proteins that were found regulated in this data set, and additional validation will have to be performed to verify if any of the mentioned proteins, or other proteins in the data set have biomarker potential. However, the full in-depth proteomic analysis is considered beyond the scope of this article.
To summarize, we here show that abundant plasma proteins, which are detected with a high number of spectra in native IF, can be used to determine barrier properties of the tumor microenvironment, e.g., the accessibility for therapeutic agents in tumor tissue. We found that the distribution volume of macromolecules between 40 and 190 kDa decreased with size for endometrial carcinoma and healthy ovarium, but was independent of molecular weight for the well-hydrated ovarian carcinoma. Furthermore, there was only effect of charge on macromolecular distribution volume at low hydration and high collagen content, indicating that a condensed interstitium increase the influence of the negative charges. We moreover found that interstitial fluid can be a valuable source for tissuespecific proteins in the search for novel biomarker candidates. Our data suggest that the highly abundant part of the tumor interstitial fluid proteome may contain reliable and clinically important data on the tumor microenvironment and tissue structure, and give indications on which ECM component to be targeted to increase uptake of macromolecular substances.
